InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Domzalski David, Chairman & CEO. Insider active across 1 company, notably VYNE Therapeutics Inc.. Cumulatively, 33 reports have been recorded. Activity tracked since 28 May 2021. The latest transaction was disclosed on 23 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Domzalski David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
79,391 shares@ US$0.89760.23% mcap14.8% of flowCommon StockSEC:0001727794-26-000010:0
14,232 shares@ US$0.59751.8% of flowCommon StockSEC:0001727794-26-000004:0
12,684 shares@ US$0.58011.7% of flowCommon StockSEC:0001727794-26-000002:0
12,676 shares@ US$0.3351.0% of flowCommon StockSEC:0001727794-25-000003:0
12,676 shares@ US$1.655.1% of flowCommon StockSEC:0001415889-25-019056:0
8,681 shares@ US$0.811.8% of flowCommon StockSEC:0001415889-25-015382:0
30,498 shares@ US$1.5811.0% of flowCommon StockSEC:0001415889-25-009629:0
24,536 shares@ US$3.3519.6% of flowCommon StockSEC:0001415889-25-000152:0
3,901 shares@ US$2.101.9% of flowCommon StockSEC:0001415889-24-028073:0
685 shares@ US$1.880.3% of flowCommon StockSEC:0001415889-24-024380:0
935 shares@ US$1.920.4% of flowCommon StockSEC:0001415889-24-019173:0
4,429 shares@ US$2.1592.2% of flowCommon StockSEC:0001415889-24-015370:0
1,004 shares@ US$3.080.7% of flowCommon StockSEC:0001415889-24-010064:0
225,000 shares0Common StockSEC:0001209191-24-000465:0
225,000 shares0Common StockSEC:0001209191-23-058815:0
2,284 shares@ US$2.81351.5% of flowCommon StockSEC:0001209191-23-057220:0
8,549 shares@ US$3.837.7% of flowCommon StockSEC:0001209191-23-051941:0
981 shares@ US$4.100.9% of flowCommon StockSEC:0001209191-23-041094:0
2,766 shares@ US$3.45632.2% of flowCommon StockSEC:0001209191-23-033783:0
2,734 shares@ US$3.081.9% of flowCommon StockSEC:0001209191-23-022790:0
10,685 shares@ US$0.150.4% of flowCommon StockSEC:0001209191-23-001066:0
34,705 shares@ US$0.19771.6% of flowCommon StockSEC:0001209191-22-059425:0
10,683 shares@ US$0.2230.6% of flowCommon StockSEC:0001209191-22-052350:0
10,683 shares@ US$0.3891.0% of flowCommon StockSEC:0001209191-22-040778:0
11,887 shares@ US$0.34630.020% mcap2.1% of flowCommon StockSEC:0001209191-22-033542:0
25 of 33 declarations
About Domzalski David
Domzalski David is Président-Directeur Général. He has 32 filings in total, all in the recent sample covered here, linked to VYNE Therapeutics Inc. (XNAS). The most recent transactions run from 2021-06-02 to 2026-04-02, and the most frequent transaction nature is Tax withholding.
